| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/02/2006 | US20060026695 Transgenically produced fusion proteins |
| 02/02/2006 | US20060026694 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 02/02/2006 | US20060025582 Promoter sequences for corticotropin releasing-factor receptor CRF2alpha and method of identifying agents that alter the activity of the promoter sequences |
| 02/02/2006 | US20060025581 Novel human GABA receptor proteins and polynucleotides encoding the same |
| 02/02/2006 | US20060025580 Novel human estrogen receptor beta |
| 02/02/2006 | US20060025576 Multivalent antibodies and uses therefor |
| 02/02/2006 | US20060025575 Hybridoma cell line producing monoclonal antibodies to bind to, to detect and qualitatively and quantitatively measure the presence of epitopes of prion proteins; neurodegenerative diseases of the central nervous system |
| 02/02/2006 | US20060025573 Reducing the immunogenicity of fusion proteins |
| 02/02/2006 | US20060025572 Mammalian cell surface antigens; related reagents |
| 02/02/2006 | US20060025570 Megakaryocyte stimulating factors |
| 02/02/2006 | US20060025374 Novel oligoribonucleotide derivatives for specific inhibition of gene expression |
| 02/02/2006 | US20060025373 Modulation of glucocorticoid receptor expression |
| 02/02/2006 | US20060025372 Antisense modulation of PTP1B expression |
| 02/02/2006 | US20060025370 Methods of inhibiting VEGF-C |
| 02/02/2006 | US20060025368 Growth hormone releasing hormone enhances vaccination response |
| 02/02/2006 | US20060025366 Short intefering sequences comprising 1,2-DiLinoleyloxy-N,N-dimethylaminopropane (DLinDMA) or 1,2-Dilinolenyloxy-N,N-dimethylaminopropane (DLenDMA) for use in silencing target gene sequences |
| 02/02/2006 | US20060025362 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 02/02/2006 | US20060025360 Human cervical cancer protooncogene and protein encoded therein |
| 02/02/2006 | US20060025356 28-epirapalogs |
| 02/02/2006 | US20060025348 Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| 02/02/2006 | US20060025339 Corticotropin releasing factor 2 receptor agonists |
| 02/02/2006 | US20060024830 Growth characteristics of filamentous microorganisms |
| 02/02/2006 | US20060024829 Adenovirus packaging cell lines |
| 02/02/2006 | US20060024828 Process of making a compound by forming a polymer from a template drug |
| 02/02/2006 | US20060024821 Rolling circle replicon expression vector |
| 02/02/2006 | US20060024820 Chromosome-based platforms |
| 02/02/2006 | US20060024819 Integration vectors |
| 02/02/2006 | US20060024812 Device for injecting substance into cell and method for injecting substance into cell |
| 02/02/2006 | US20060024811 Storing data encoded DNA in living organisms |
| 02/02/2006 | US20060024810 Method of atttaching nanotubes to bacteria and applications |
| 02/02/2006 | US20060024809 Ceramidase gene |
| 02/02/2006 | US20060024808 Covalent tethering of functional groups to proteins and substrates therefor |
| 02/02/2006 | US20060024807 Kinase nucleic acids and polypeptides encoded by these nucleic acids; kinase inhibiitor design and indentifying inhibitors |
| 02/02/2006 | US20060024806 Mycolactone locus: an assembly line for producing novel polyketides, therapeutic and prophylactic uses |
| 02/02/2006 | US20060024804 Isoforms isolated and purified from mammalian colostrum |
| 02/02/2006 | US20060024799 Method for linear mRNA amplification |
| 02/02/2006 | US20060024798 Gene knockout; gene overexpression; liposomes |
| 02/02/2006 | US20060024797 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes |
| 02/02/2006 | US20060024796 Transcriptional activator gene for genes involved in cobalamin biosynthesis |
| 02/02/2006 | US20060024795 Interferon-Like molecules and uses thereof |
| 02/02/2006 | US20060024794 Novel methods for production of di-chain botulinum toxin |
| 02/02/2006 | US20060024792 G-protein coupled receptors |
| 02/02/2006 | US20060024790 Recombinant cage-like protein, method for producing the same, precious metal-recombinant cage-like protein complex, method for producing the same and recombinant DNA |
| 02/02/2006 | US20060024788 Inducible alphaviral gene expression system |
| 02/02/2006 | US20060024785 Having mutations in the Kinase domain region (KDR) and/or the FMS-like Tyrosine-Kinase region (FLT-1), said variants exhibiting modified binding characteristics at said regions compared with native VEGF; stimulates vasculogenesis or angiogenesis; wound healing |
| 02/02/2006 | US20060024784 Phenol oxidizing enzymes |
| 02/02/2006 | US20060024782 Production of a monoclonal antibody in a heterokaryon filamentous fungus or in a filamentous fungal host cell |
| 02/02/2006 | US20060024773 Method for measuring intracellular gene transcription using blue luciferase from dinoflagellate |
| 02/02/2006 | US20060024766 Bifunctional molecules |
| 02/02/2006 | US20060024760 Human brain carboxypeptidase B |
| 02/02/2006 | US20060024754 Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 02/02/2006 | US20060024747 Comprises nucleotide sequences coding nitrillase and amidase for transformation and propagation of microorganism capable of catalyzing hydration of certain nitrites to corresponding amides and amides to corresponding carboxylic acids |
| 02/02/2006 | US20060024741 Support for fixing nucleotide and process for producing the same |
| 02/02/2006 | US20060024738 Site- or sequence-specific process for cleaving analytes and library of analytes |
| 02/02/2006 | US20060024737 Endocnucleases; real time detection; enzyme resistance; chimera |
| 02/02/2006 | US20060024735 Chimeric nucleic acid constructs and compositions comprising sets of nucleic acid constructs |
| 02/02/2006 | US20060024731 Forming a ligation product on a target nucleotide sequence; amplifying the product; detecting the amplified product, and identifying the target nucleotide sequence; multiplex methods |
| 02/02/2006 | US20060024728 GM-CSF and/or defensin protein expression regulators in epithelial cells comprising ETS transcription factor or gene encoding the same |
| 02/02/2006 | US20060024727 Antisense modulation of C-reactive protein expression |
| 02/02/2006 | US20060024726 Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| 02/02/2006 | US20060024709 Methods for nucleic acid manipulation |
| 02/02/2006 | US20060024708 Porcine sulfotransferase 2A1 polynucleotide sequence, protein, and methods of use for same |
| 02/02/2006 | US20060024701 Methods and reagents for the isolation of nucleic acids |
| 02/02/2006 | US20060024697 Compositions and methods for binding agglomeration proteins |
| 02/02/2006 | US20060024696 Nucleic acid and polypeptide sequences from Lawsonia intracellularis and methods of using |
| 02/02/2006 | US20060024687 In vitro evolution of nucleic acids and encoded polypeptide |
| 02/02/2006 | US20060024686 Detection of human papillomaviruses |
| 02/02/2006 | US20060024683 Transcription factor of MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substances |
| 02/02/2006 | US20060024679 Method for predicting the expression efficiency in cell-free expression systems |
| 02/02/2006 | US20060024675 Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used |
| 02/02/2006 | US20060024672 Verification of food origin based on nucleic acid pattern recognition |
| 02/02/2006 | US20060024669 Using influenza virus peptide as tool in diagnosis and treatment of viral diseases; proteomics; bioinformatics |
| 02/02/2006 | US20060024668 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/02/2006 | US20060024666 Humanized antibodies against the venezuelan equine encephalitis virus |
| 02/02/2006 | US20060024329 Recombinant live vaccine based on canine herpesvirus, in particular against Carre's disease, rabies or the parainfluenza virus type 2. |
| 02/02/2006 | US20060024324 Glutamate-rich protein (GLURP) genetically coupled to plasmodium falciparum merozoite surface protein 3 (MSP3) for use as tool in preventing malarial infection; Antimalarial agents; parasiticides |
| 02/02/2006 | US20060024321 chemokines; open reading frames; long terminal repeats; site directed mutagenesis; antibodies |
| 02/02/2006 | US20060024320 Attenuated pestiviruses |
| 02/02/2006 | US20060024319 determining whether a mouse is infected with murine norovirus-1 by determining presence, absence or quantity of antibody against MNV-1 a sample of a mouse; the antibody binds to MNV-1 deposited as American Type Culture Collection (ATCC) Deposit No. PTA-5935 or to a polypeptide encoded by it |
| 02/02/2006 | US20060024316 Prostatic cancer vaccine |
| 02/02/2006 | US20060024300 Immunoglobulin variants and uses thereof |
| 02/02/2006 | US20060024299 Human osteoclast derived cathepsin |
| 02/02/2006 | US20060024293 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 02/02/2006 | US20060024280 Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis |
| 02/02/2006 | US20060024279 Retroviral vectors |
| 02/02/2006 | US20060024275 Methods for use of MPL ligands with primitive human stem cells |
| 02/02/2006 | US20060024274 Retroviral vectors |
| 02/02/2006 | US20060024273 Target cell-specific adenoviral vectors containing E3 and methods of use thereof |
| 02/02/2006 | US20060024267 TNFr/OPG-like molecules and uses thereof |
| 02/02/2006 | US20060024250 Electroless method comprising mixing an acidified metal halide salt solution with a supersaturated sol where the ssalt is reduced and cerystallized to form monodispersed single crystal metal platetets; gold; silica sols; drug delivery vehicles; cosmetics; nail polishes; eye liners |
| 02/02/2006 | US20060024240 Delivery of as-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes |
| 02/02/2006 | US20060024234 Protein markers for pharmaceuticals and related toxicity |
| 02/02/2006 | US20060024233 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 02/02/2006 | US20060024231 Tissue-specific imaging and therapeutic agents targeting proteins expressed on lung endothelial cell surface |
| 02/02/2006 | US20060021651 Liquid delivery device |
| 02/02/2006 | DE19856463B4 Retrovirale, mit LCMV pseudotypisierte Hybrid-Vektoren Retroviral pseudotyped with LCMV hybrid vectors |
| 02/02/2006 | DE102004034433A1 Verfahren zur Reinigung und Isolierung von Nukleinsäuren unter Verwendung kationischer Detergentien A process for the purification and isolation of nucleic acids using cationic detergents |
| 02/02/2006 | DE102004032888A1 Isolated nucleic acid, coded for a fusion protein, is formed by two functionally bonded nucleic acid sequences where one is derived from a mycovirus |
| 02/02/2006 | CA2579753A1 Non-integrative and non-replicative lentivirus, preparation and uses thereof |
| 02/02/2006 | CA2579674A1 Method for preventing dehiscence and altering plant lignification |